{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T22:40:42Z","timestamp":1772923242130,"version":"3.50.1"},"reference-count":28,"publisher":"Japan Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1507\/endocrj.ej25-0427","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:09:55Z","timestamp":1767650995000},"page":"461-470","source":"Crossref","is-referenced-by-count":0,"title":["Dysregulation of miR-642a-5p is involved in the regulation of pancreatic \u03b2-cell function &lt;i&gt;via&lt;\/i&gt; &lt;i&gt;Mef2d&lt;\/i&gt;"],"prefix":"10.1507","volume":"73","author":[{"given":"Meixiao","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Basic Medicine, Cangzhou Medical College, Hebei 061001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Yue","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, Cangzhou Medical College, Hebei 061001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linqi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, Xingtai Medical College, Hebei 054000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Cangzhou Hospital of Integrated TCM-WM, Hebei 061001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5924-5795","authenticated-orcid":false,"given":"Yin","family":"Pang","sequence":"additional","affiliation":[{"name":"Department of Basic Medicine, Cangzhou Medical College, Hebei 061001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, et al. (2022) IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 183: 109119.","DOI":"10.1016\/j.diabres.2021.109119"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Yaribeygi H, Sathyapalan T, Atkin SL, Sahebkar A (2020) Molecular mechanisms linking oxidative stress and diabetes mellitus. Oxid Med Cell Longev 2020: 8609213.","DOI":"10.1155\/2020\/8609213"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Eliasson L, Regazzi R (2020) Micro(RNA) Management and mismanagement of the Islet. J Mol Biol 432: 1419\u20131428.","DOI":"10.1016\/j.jmb.2019.09.017"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Zhao D, Zhang X, Bian Y, Meng L, Wu Y, et al. (2023) Taurine reduces apoptosis mediated by endoplasmic reticulum stress in islet \u03b2-cells induced by high-fat and -glucose diets. Food Chem Toxicol 175: 113700.","DOI":"10.1016\/j.fct.2023.113700"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Park JE, Han JS (2023) Scopoletin protects INS-1 pancreatic \u03b2 cells from glucotoxicity by reducing oxidative stress and apoptosis. Toxicol In Vitro 93: 105665.","DOI":"10.1016\/j.tiv.2023.105665"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Cheung R, Pizza G, Chabosseau P, Rolando D, Tomas A, et al. (2022) Glucose-dependent miR-125b is a negative regulator of \u03b2-cell function. Diabetes 71: 1525\u20131545.","DOI":"10.2337\/db21-0803"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Grieco GE, Brusco N, Fignani D, Nigi L, Formichi C, et al. (2022) Reduced miR-184-3p expression protects pancreatic \u03b2-cells from lipotoxic and proinflammatory apoptosis in type 2 diabetes <i>via<\/i> CRTC1 upregulation. Cell Death Discov 8: 340.","DOI":"10.1038\/s41420-022-01142-x"},{"key":"8","unstructured":"8 Laakso M (2001) Insulin resistance and its impact on the approach to therapy of type 2 diabetes. Int J Clin Pract Suppl: 8\u201312."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 de Jesus DS, Mak TCS, Wang YF, von Ohlen Y, Bai Y, et al. (2021) Dysregulation of the Pdx1\/Ovol2\/Zeb2 axis in dedifferentiated \u03b2-cells triggers the induction of genes associated with epithelial-mesenchymal transition in diabetes. Mol Metab 53: 101248.","DOI":"10.1016\/j.molmet.2021.101248"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Ofori JK, Karagiannopoulos A, Nagao M, Westholm E, Ramadan S, et al. (2022) Human islet microRNA-200c is elevated in type 2 diabetes and targets the transcription factor ETV5 to reduce insulin secretion. Diabetes 71: 275\u2013284.","DOI":"10.2337\/db21-0077"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Sun X, Ji G, Li P, Li W, Li J, et al. (2021) miR-344-5p modulates cholesterol-induced \u03b2-cell apoptosis and dysfunction through regulating caveolin-1 expression. Front Endocrinol (Lausanne) 12: 695164.","DOI":"10.3389\/fendo.2021.695164"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Shi HQ, Li X, Chen Z, Dong S, Ye C, et al. (2024) KRT19 is regulated by miR-642a-5p and promotes pancreatic cancer progression through the Wnt\/\u03b2-catenin pathway. iScience 27: 110782.","DOI":"10.1016\/j.isci.2024.110782"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Beveridge DJ, Richardson KL, Epis MR, Brown RAM, Stuart LM, et al. (2021) The tumor suppressor miR-642a-5p targets Wilms Tumor 1 gene and cell-cycle progression in prostate cancer. Sci Rep 11: 18003.","DOI":"10.1038\/s41598-021-97190-x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Luo J, Wang Y, Dong X, Wang W, Mu Y, et al. (2022) miR-642a-5p increases glucocorticoid sensitivity by suppressing the TLR4 signalling pathway in THP-1 cells. Biochem Biophys Rep 32: 101356.","DOI":"10.1016\/j.bbrep.2022.101356"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 American Diabetes Association (2021) 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2021. Diabetes Care 44(Suppl 1): S15\u2013S33.","DOI":"10.2337\/dc21-S002"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Liu Y, Wang Y, Shen X, Chen C, Ni H, et al. (2020) Down-regulation of lncRNA PCGEM1 inhibits cervical carcinoma by modulating the miR-642a-5p\/LGMN axis. Exp Mol Pathol 117: 104561.","DOI":"10.1016\/j.yexmp.2020.104561"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17 Fei L, Sun G, You Q (2020) miR-642a-5p partially mediates the effects of lipopolysaccharide on human pulmonary microvascular endothelial cells <i>via<\/i> eEF2. FEBS Open Bio 10: 2294\u20132304.","DOI":"10.1002\/2211-5463.12969"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Szeto ACH, Clark PA, Ferreira ACF, Heycock M, Griffiths EL, et al. (2024) Mef2d potentiates type-2 immune responses and allergic lung inflammation. Science 384: eadl0370.","DOI":"10.1126\/science.adl0370"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Xiang J, Zhang N, Du A, Li J, Luo M, et al. (2023) A ubiquitin-dependent switch on MEF2D senses pro-metastatic niche signals to facilitate intrahepatic metastasis of Liver Cancer. Adv Sci (Weinh) 10: e2305550.","DOI":"10.1002\/advs.202305550"},{"key":"20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/SHK.0000000000001844","volume":"57","author":"L Shi","year":"2022","unstructured":"20 Shi L, Li B, Chen G, Huang Y, Tian Z, et al. (2022) MEF2D participates in microglia-mediated neuroprotection in cerebral ischemia-reperfusion rats. Shock 57: 118\u2013130.","journal-title":"Shock","ISSN":"https:\/\/id.crossref.org\/issn\/1073-2322","issn-type":"print"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Yoshida M, Yokoi N, Takahashi H, Hatano N, Hayami T, et al. (2022) O-GlcNAcylation of myocyte-specific enhancer factor 2D negatively regulates insulin secretion from pancreatic \u03b2-cells. Biochem Biophys Res Commun 605: 90\u201396.","DOI":"10.1016\/j.bbrc.2022.03.036"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Sun C, Wen X, Chu X, Yuan F, Chen Y, et al. (2025) Adipocyte exosome miR-4472 inhibits glucose uptake in skeletal muscle through downregulation of MEF2D. J Diabetes Investig 16: 1382\u20131397.","DOI":"10.1111\/jdi.70054"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Cao J, Chen C, Chen Q, Gao Y, Zhao Z, et al. (2022) Extracellular vesicle miR-32 derived from macrophage promotes arterial calcification in mice with type 2 diabetes <i>via<\/i> inhibiting VSMC autophagy. J Transl Med 20: 307.","DOI":"10.1186\/s12967-022-03502-8"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24 Zhu X, Oguh A, Gingerich MA, Soleimanpour SA, Stoffers DA, et al. (2021) Cell cycle regulation of the Pdx1 transcription factor in developing pancreas and insulin-producing \u03b2-cells. Diabetes 70: 903\u2013916.","DOI":"10.2337\/db20-0599"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Sharma R, Maity SK, Chakrabarti P, Katika MR, Kapettu S, et al. (2023) PIMT controls insulin synthesis and secretion through PDX1. Int J Mol Sci 24: 8084.","DOI":"10.3390\/ijms24098084"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Bao X, Li J, Ren C, Wei J, Lu X, et al. (2022) Aucubin ameliorates liver fibrosis and hepatic stellate cells activation in diabetic mice <i>via<\/i> inhibiting ER stress-mediated IRE1\u03b1\/TXNIP\/NLRP3 inflammasome through NOX4\/ROS pathway. Chem Biol Interact 365: 110074.","DOI":"10.1016\/j.cbi.2022.110074"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Ge MH, Tian H, Mao L, Li DY, Lin JQ, et al. (2021) Zinc attenuates ferroptosis and promotes functional recovery in contusion spinal cord injury by activating Nrf2\/GPX4 defense pathway. CNS Neurosci Ther 27: 1023\u20131040.","DOI":"10.1111\/cns.13657"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Niu F, Liu W, Ren Y, Tian Y, Shi W, et al. (2024) \u03b2-cell neogenesis: a rising star to rescue diabetes mellitus. J Adv Res 62: 71\u201389.","DOI":"10.1016\/j.jare.2023.10.008"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/3\/73_EJ25-0427\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T03:50:57Z","timestamp":1772855457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/3\/73_EJ25-0427\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej25-0427","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"EJ25-0427"}}